Table 2.
Estimated crude and adjusted odds ratios for a logistic regression model assessing effects of factors on the perception of playing an important role in cancer cachexia management (n = 237)
| Independent variables | Crude OR (95% CI) | P value | Adjusted OR (95% CI) | P value |
|---|---|---|---|---|
| Practicing experience of cancer care | ||||
| 1–2 years | 1.00 (reference) | 1.00 (reference) | ||
| 3–4 years | 1.78 (0.43–7.44) | 0.429 | 0.85 (0.16–4.64) | 0.853 |
| 5–9 years | 3.32 (1.04–10.62) | 0.043 | 1.25 (0.30–5.22) | 0.757 |
| 10–19 years | 3.36 (1.05–10.78) | 0.041 | 1.42 (0.34–5.91) | 0.633 |
| 20 years or more | 7.12 (1.60–31.72) | 0.010 | 8.32 (1.22–56.70) | 0.030 |
| Number of patients with advanced cancer/month | ||||
| 1–9 | 1.00 (reference) | 1.00 (reference) | ||
| 10–19 | 3.43 (1.61–7.30) | 0.001 | 2.88 (1.12–7.43) | 0.029 |
| 20–49 | 3.15 (1.40–7.09) | 0.005 | 1.53 (0.53–4.37) | 0.430 |
| 50 or more | 15.46 (4.32–55.36) | < 0.001 | 27.35 (3.99–187.24) | 0.001 |
| Primary area of practice | ||||
| Other | 1.00 (reference) | 1.00 (reference) | ||
| Cancer treatment | 2.01 (0.99–4.07) | 0.053 | 1.83 (0.76–4.40) | 0.177 |
| Palliative care | 2.65 (1.37–5.14) | 0.004 | 1.32 (0.55–3.14) | 0.536 |
| Number of clinical guidelines used in clinical practice | ||||
| 0 | 1.00 (reference) | 1.00 (reference) | ||
| 1–4 | 4.58 (2.52–8.33) | < 0.001 | 2.69 (1.29–5.61) | 0.008 |
| Number of items used in the assessment of cancer cachexia | ||||
| 0–4 | 1.00 (reference) | 1.00 (reference) | ||
| 5–8 | 3.94 (2.04–7.60) | < 0.001 | 3.52 (1.47–8.40) | 0.005 |
| Number of symptoms used in the assessment of cancer cachexia | ||||
| 0–5 | 1.00 (reference) | 1.00 (reference) | ||
| 6–10 | 1.24 (0.67–2.31) | 0.498 | 0.69 (0.30–1.57) | 0.379 |
| 11–15 | 4.03 (1.83–8.86) | 0.001 | 2.06 (0.73–5.85) | 0.174 |
| Training for cancer cachexia management | ||||
| No | 1.00 (reference) | 1.00 (reference) | ||
| Yes | 4.51 (2.39–8.49) | < 0.001 | 3.91 (1.77–8.67) | 0.001 |
A multivariate model adjusted for practicing experience of cancer care, the number of patients with advanced cancer/month, the primary area of practice, the number of clinical guidelines used in clinical practice, the number of items used in the assessment of cancer cachexia, the number of symptoms used in the assessment of cancer cachexia, and training for cancer cachexia management
OR odds ratio, CI confidence interval